Adam R Craig
CIK 1339498 · Executive Chairman · last filed 2025-10-31
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.50M
Companies
3
Total Filings
31
Lifetime Open-Market Net
-$4.83M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XFOR | Executive Chairman | 376,087 | $4.00 | $1.50M | $250.0K | 3 | 2025-10-31 |
| CTI BIOPHARMA CORP (CTIC) Delisted | President and CEO | 0 | $9.09 | $0 | -$5.06M | 19 | 2023-06-26 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | EVP, Development & CMO | 31,754 | $18.62 | $591.3K | -$20.4K | 6 | 2015-03-02 |
Recent Filings · Page 2 of 4
31 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-07-06 | CTI BIOPHARMA CORP (CTIC) Delisted | Mixed | +6,183 | -$361.5K | EDGAR |
| 2022-06-03 | CTI BIOPHARMA CORP (CTIC) Delisted | Exer (M) | — | $0 | EDGAR |
| 2022-06-03 | CTI BIOPHARMA CORP (CTIC) Delisted | Mixed | — | -$372.8K | EDGAR |
| 2022-03-11 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | +3,178 | $6.7K | EDGAR |
| 2021-12-02 | CTI BIOPHARMA CORP (CTIC) Delisted | Mixed | +8,500 | $16.0K | EDGAR |
| 2021-03-12 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | +5,000 | $4.9K | EDGAR |
| 2020-03-13 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-20 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-09-20 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-17 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.